PharmD Info

A forum for Indian Pharmacy Professionals

Latest Indian Pharma News, Pharmacist Day Celebrations, Pharmacy Council of India Notifications, Seminars and Conferences Alerts. Marketing News
Forum rules: Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
#110
Washington, 23 Drugs often given to HIV-positive pregnant women may cause significant long-term heart problems for the non-HIV-infected babies they carry, a new study suggests.

The study shows that while the HIV medications have been successful in helping to prevent the transmission of the virus from mother to infant, they are associated with persistently impaired development of heart muscle and reduced heart performance in non-HIV-infected children whose mothers received the medicines years earlier.

"What our study indicates is that there's potentially a long-term price to be paid for protecting the children of HIV-infected mothers from the virus," said Steven Lipshultz, pediatrician-in-chief at the Children's Hospital of Michigan and chair of pediatrics for the Wayne State University School of Medicine.

"These medicines have been very effective at reducing the rate of transmission of HIV from mother to child, but the findings we've just published show clearly that further investigation of their long-term impact on the heart health of the children involved is needed," said Lipshultz, the lead author of the study.

"Thanks to the new anti-HIV medications, the rate of transmission has been lowered from 26 per cent to less than 1 per cent during the past few decades, and that has been a miracle of life for the children involved. Still, we don't want to be protecting these children from one disease, only to give them another one," said Lipshultz.

The study compared heart development and long-term heart functioning in 428 uninfected children of HIV-infected mothers to children who had not been exposed to HIV from 2007 to 2012.

The results pointed to a significant association between lagging heart muscle development and impaired pumping ability in the children of the HIV-infected mothers who had received the medications.

"Subclinical differences in left ventricular structure and function with specific in-utero antiviral exposures indicate the need for a longitudinal study to assess long-term cardiac risk and cardiac monitoring recommendations," said Lipshultz.
Similar Topics
Topics Statistics Last post
0 Replies 
933 Views
by Admin
30 Jul 2020, 11:13
3 Replies 
6207 Views
by Admin
07 Mar 2018, 15:32
4 Replies 
9516 Views
by rahmatulla.syed
31 Oct 2019, 00:33
0 Replies 
4642 Views
by unbreakable
04 Sep 2019, 14:49
1 Replies 
1704 Views
by Naghul adhithya k s
04 Mar 2020, 09:52

To register as a pharmacist in New Zealand, an app[…]

Dear all, As you may aware that we used to commun[…]

UGC Revised Guidelines on Examinations and Academi[…]

The medical writer in a CRO develops regulatory do[…]

E-Learn Portal